Introduction
Bacteria produce a large variety of protein toxins with intracellular targets, and also plants contain similar toxic proteins (for recent reviews about toxins containing both a binding moiety and an enzymatically active moiety, as well as toxic proteins without a binding moiety, see Sandvig and van Deurs, 1 Hartley and Lord, 2 Sandvig et al, 3, 4 Turton et al 5 ). The schematic structure and the activity of some of these toxins are shown in Figure 1 . All of the plant toxins studied so far and several of the bacterial toxins (the Shiga toxins) block protein synthesis by removing one adenine from the 28S ribosomal RNA of the 60S subunit, thereby blocking protein synthesis. Diphtheria toxin and Pseudomonas exotoxin A inhibit protein synthesis by inactivation of elongation factor 2. Bacterial toxins have a number of different target molecules, ranging from kinases to actin and Rho proteins. 1, 6 Common to all these toxins, regardless of the target molecule, is that they have to enter the cytosol to exert their effects. Therefore, studies of these toxins have provided us with knowledge of how an external molecule might reach the cytosol. As described below, and as indicated in Figure 2 , the toxins use two main pathways to gain access to the cytosol. They can be transferred from endosomes (early or late) in response to low pH, or they can enter the Golgi and then the ER and be transferred to the cytosol from this destination. Toxins normally entering from acidic endosomes can even in some cases, as first shown for diphtheria toxin, 7, 8 be induced to enter directly from the cell surface in response to external low pH. Not only do the toxins reveal the different intracellular mechanisms that can be used to enter the cytosol, it turns out that they can in themselves be used as vectors to bring in epitopes to be presented by MHC class I, 9 they can bring in intact proteins, 10, 11 and in some cases it turns out that they might even be used to transfer nucleotides into the cytosol and the nucleus of cells. [12] [13] [14] [15] [16] [17] [18] [19] These aspects of the toxins are described in the paragraphs below.
terminal galactose, provided some of the early evidence for clathrin-independent endocytosis. 21, 22 In fact, clathrin-dependent endocytosis was during many years believed to account for all uptake from the cell surface. It is now known that several mechanisms exist, both clathrin-dependent and -independent processes operate in the same cell, and as described below in the paragraph about transcytosis, the clathrin-independent mechanism(s) can be subjected to regulation by a number of signalling pathways. Furthermore, when it comes to Figure 1 Schematic overview of some bacterial and plant toxins. The enzymatically active subunit is denoted A. However, as indicated, in some cases this subunit is cleaved into A 1 and A 2 , where A 1 is the one with enzymatic activity. The B moiety is the part of the toxin responsible for binding to cell surface receptors. In the figure, also the enzymatic activity and the intracellular targets are listed. The arrows indicate sites where cellular enzymes cleave and activate the toxins. For the properties and structure of more toxins, please see recent reviews, such as Sandvig and van Deurs. Lessons learned from plant and bacterial toxins K Sandvig and B van Deurs clathrin-independent processes, different molecules can be involved (perhaps in a cell-type specific manner?). For instance, it has been described that uptake of GPIanchored proteins can be dependent on cdc42 in CHO cells, 23 whereas this does not seem to be the case in HeLa cells. 24 Furthermore, the clathrin-independent endocytosis can be dependent on lipid rafts (domains rich in cholesterol and sphingolipids), 25 or it can be raftindependent. 26, 27 Clathrin-independent endocytosis can also operate with 25 and without dynamin 26, 27 as an essential molecule. Thus, clathrin-independent uptake of the IL2 receptor is dependent on lipid rafts, 25 whereas ricin and cholera toxin can be internalized under conditions where clathrin-dependent uptake is inhibited and cholesterol has been depleted from the rest of the membrane. 26, 28 In the case of anthrax toxin, the uptake is dependent on lipid rafts for the initiation of processing (protective antigen (PA) heptamerization, cleavage of PA and subsequent binding of lethal factor (LF)), and then the toxin (the complex of PA and LF) is taken in by a clathrin-dependent process. 29 One danger in using protein toxins to study a given process is that the toxin might induce signalling that could affect the process. For instance, both Shiga toxin and cholera toxin, which bind to the glycosphingolipids Gb3 and GM1, respectively, are known to affect signalling pathways. 3, 30, 31 In this context, it should be noted that both these toxins lead to crosslinking of their receptors since they are multivalent. A subtype of lipid rafts are caveolae, 50-70 nm invaginated portions of the plasma membrane associated with the protein caveolin. Caveolae are normally quite stable, 32 but they can be involved in uptake of cholera toxin. However, so far it is not known to which extent cholera toxin in some cells can induce pinching off of some caveolae, or whether some cholera toxin becomes internalized by a small fraction of caveolae which for unknown reasons are not stabilized at the plasma membrane. The internalization of caveolae may at least in some cases be dependent on tyrosine phosphorylation and actin reorganization 33 or regulated by addition of cholesterol and glycolipids. 34 Importantly, it has recently been published that cholera toxin taken up from caveolar structures ends up in normal acidified endosomes, 35 simlarly as we have found for diphtheria toxin bound to a receptor with a GPI anchor (see below). 36 That endocytic compartments are able to exchange contents makes it less critical in the present context whether a ligand is taken up from caveolae or clathrin-coated pits. Diphtheria toxin is ideal to investigate whether the receptor molecule it binds to is internalized into an acidic compartment. For instance, when diphtheria toxin was bound to its receptor modified to contain a GPI-anchor instead of the normal transmembrane/cytosolic domain, the toxin was, in contrast to when bound to its normal receptor, internalized by clathrin-independent endocytosis. 36 This GPIanchored receptor was internalized into an acidified organelle, presumably an endosome, since the toxin was translocated to the cytosol and intoxicated the cell. Thus, although there are -as with other approaches -pitfalls when it comes to studies of endocytosis using protein toxins, they have proven very important for our understanding of the endocytic mechanims.
Direct transport from endosomes to the cytosol
To which extent can transport of proteins and nucleotides to the cytosol occur from endosomes? It is now 25 years since it was discovered that diphtheria toxin enters from endosomes in response to the relatively low pH found in this organelle, and that direct entry from the cell surface can be induced by exposing cells with surface-bound toxin to low pH, thereby mimicking the conditions in the endosomes (see Table 1 ). 7, 8 Thus, it became clear that low pH is sufficient to drive the translocation of the receptor-bound toxin across the membrane. The low endosomal pH triggers a conformational change in the toxin molecule, 37 leading to exposure of hydrophobic areas that are inserted into the membrane, and then the enzymatically active part of the toxin is translocated. During membrane insertion and translocation of the toxin there is a concomitant formation of cation-selective pores, 38 but the role of the pores is not known. It is still not clarified whether the A-fragment actually passes through the pore. It is important to note that although a number of studies have been performed with diphtheria toxin and artificial lipid membranes, 39 these systems do not necessarily reflect what goes on during toxin transport in an intact cell. For instance, in cells the receptor seems to be essential for translocation, 36, 38 and changes of the cytosolic tail of the receptor have been shown to protect against the toxin.
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During the last two decades, a number of other protein toxins have been found to use a similar mechanism (for recent reviews, see Sandvig and van Deurs, 1 Turton et al 4 ), and in several cases the same test system as applied to diphtheria toxin has been used: Can the (7) and toxins may then continue to lysosomes (8) for degradation. EE, early endosomes; SE sorting endosomes; LE, late endosomes; LY, lysosomes.
Lessons learned from plant and bacterial toxins K Sandvig and B van Deurs surface-bound toxin enter the cytosol directly across the plasma membrane when exposed to low pH? The group of toxins that enters in response to low endosomal pH includes in addition to diphtheria toxin, anthrax toxin, Clostridial neurotoxins, cytotoxic necrotizing factor 1 (CNF1), Clostridium botulinum C2 toxin, Clostridium difficile toxin B, and Pasteurella multodica toxin (PMT). Although the toxins do not disrupt the endosomal membrane leading to a general release of vesicle content (see below), they can still be used to transport other molecules into the cell. For instance, ricin A-chain can be brought into the cytosol when bound to diphtheria toxin B-chain via a disulfide bond, 41 and similarly as found with diphtheria toxin, the cells are protected against this molecule by compounds that abolish low pH in endosomes. Furthermore, acidic fibroblast growth factor can, bound to diphtheria toxin, be brought into the cytosol, 10 and also C. botulinum exoenzyme C3 can enter the cytosol of cells by coupling it (on a genetic level) to diphtheria toxin B.
11 However, the mechanism of entry is not identical to that of diphtheria toxin since it cannot be pulsed in from the cell surface. Also, cell-specific differences can give rise to surprises when it comes to the abililty of a given compound to enter the cytosol. Cell differences may for instance explain some of the apparent disagreements on the ability or inability of cell permeable peptides with or without additional cargo to enter cells. 42 Both toxins and peptides may function as vectors to bring in other molecules although the mechanisms involved may differ from what one originally thought.
Toxins can also be used to test for disruption of endosomes caused by other agents. The toxin gelonin, which belongs to a group of toxins with an A-chain only (also called RIPs for ribosome-inactivating proteins), 2, 43 can inactivate ribosomes after entry into the cytosol. Without a binding moiety this toxin is taken up only by fluid-phase endocytosis and is free to diffuse into the cytosol after disruption of the endosomal membrane. For instance, gelonin is released to the cytosol after treatment of cells with phorphyrins and subsequent light treatment that leads to disruption of endosomes and release of content. 44 A number of different agents have been used to increase release of DNA into the cytosol. 45 Such agents include virus, cationic polymers, and lysosomotropic agents such as chloroquine. 45, 46 In the case of adenovirus and peptides derived from Heamophilus influenza hemagglutinin from influenza virus, low pH-induced effects on the virus or the virus peptides are involved in the disruption of endosomes and increased DNA transfer to the cytosol. This is in contrast to diphtheria toxin that does not seem to disrupt endosomes, since it does not mediate release of gelonin and intoxication of cells that are resistent to diphtheria toxin due to a mutation of elongation factor 2 (our own unpublished data). If the endosomes had been disrupted, released gelonin would have attacked the ribosomes. Also, the lysosomotropic compound chloroquine turns out to increase transfer of DNA to the cytosol. 45 The mechanism behind this is not clear. The increase could be due to an inhibition of transfer to the lysosome since endosome to lysosome transport is inhibited by increased pH, 47 or it could be due to swelling of endosomes and destabilization of the membrane, thereby inducing some leakiness. Interestingly, the ionophore monensin that can also increase endosomal pH is able to sensitize cells to the protein toxin ricin. 48 Again, the mechanism behind this sensitization is not known. It could be due to increased retrograde transport to the Golgi and the ER, and importantly, there is some sentization also at monensin concentrations that are so low that they are unlikely to affect endosomal pH. Whether these conditions can affect DNA transfer have, to our knowledge, not been tested.
Transport to the lysosomes
A certain fraction of internalized toxins are transported to the lysosomes where they are then degraded. However, the protein toxin ricin is very resistant to proteolytic degradation, making the protein a useful tool also to study the transport of a membrane-marker from the cell surface to lysosomes. By using ricin, we earlier found evidence for the involvement of actin in this process. 49 Actually disruption of actin inhibited ricin degradation more than was the case after disruption of microtubules. Furthermore, ricin was used to quantify sorting to the various compartments such as the Golgi apparatus versus lysosomes, 50 and it was discovered that the valency of this ligand was important for its destiny. 51 Multivalent complexes of ricin and HRP as well as ricin coupled to gold particles were sent directly to lysosomes, whereas monovalent ricin had the ability to be transported also to the Golgi apparatus. Similarly, evidence for the importance of valency for sorting has been obtained from other systems. 52, 53 Thus, how one produces a compound (the valency of the resulting conjugate) can define destiny of the resulting product.
Recycling of internalized material
A fraction of endocytosed molecules are, instead of being delivered to the lysosomes, transported to the Golgi Some of the first studies demonstrating recycling of endocytosed material was made by using ricin. 54 
1980
Direct membrane penetration of a protein in response to low pH: studies with diphtheria toxin. 7, 8 1982 Endocytosis is required for transport to the cytosol also of toxins not requiring low pH. 48 
1985-1987
Evidence for clathrin-independent endocytosis. 21, 22 1986
The valency of an internalized toxin is essential for its intracellular destiny. 51 
1992
First demonstration of retrograde transport all the way from the cell surface to the Golgi apparatus, the ER and the nuclear envelope. 57 These studies were performed by using Shiga toxin. 1999
A GPI-anchored diphtheria toxin receptor is endocytosed by clathrin-and caveolin-independent endocytosis into an acidic compartment. 36 Lessons learned from plant and bacterial toxins K Sandvig and B van Deurs apparatus, transported across the cell layer (transcytosis in polarized epithelial or endothelial cells), or recycled to the cell surface. 1 Actually, some of the earliest evidence for the existence of recycling was obtained by studying the protein toxin ricin (Table 1) . 54 Since then, our knowledge about recycling of endocytosed molecules to the cell surface is dramatically increased, 55 and the molecules involved in the process are partly identified. Also, recycling seems to involve more than one process. It may occur directly from early sorting endosomes, it can be mediated by the perinuclear-recycling compartment, and there seems to be export to the surroundings even from later endocytic compartments. Recycling can be inhibited by certain drugs that increase endosomal pH, for example, by monensin and chloroquine, that is by conditions that might facilitate transport of some gene conjugates to the cytosol. 45 In polarized cells, recycling from the two poles are different (see below). Also in polarized cells, the recycling pathways have been investigated not only by studies of fluid transport but also by quantifying the trafficking of membrane-bound markers such as the plant toxin ricin.
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Retrograde toxin transport from endosomes to the Golgi, the ER, and the cytosol In contrast to the group of toxins entering the cytosol from endosomes, there is a second group of the protein toxins that travels all the way from the cell surface to endosomes, through the Golgi appparatus and to the ER before they are translocated to the cytosol, presumably through the Sec61p channel which is important for cotranslational translocation of peptides into the ER and for transport of misfolded proteins out of the ER. 1, 5, 56, 57 The efficiency of routing between endosomes and the Golgi apparatus, that is, the fraction of endocytosed toxin that enters the Golgi is toxin-and cell-type dependent, and can even vary depending on the growth conditions. However, often not more than 5-10% of the endocytosed toxin is transported in the direction of the Golgi apparatus.
1 Recent studies from a number of laboratories have revealed that both endosome to Golgi transport and retrograde transport from the Golgi to the ER comprise several pathways. Toxins such as ricin, cholera toxin and Shiga toxin do not seem to travel through late endosomes, but instead, they are transported from early endosomes to the Golgi. 1,5 However, even the requirements for this transport step is different for ricin and Shiga toxin. 56 For instance, for efficient transport of Shiga toxin, there is a requirement for clathrin, 58, 59 whereas this is not the case for ricin. 5 However, it can be difficult to study intracellular pathways by blocking certain routes. By expressing dominant negative mutants of the proteins involved, alternative transport mechanisms can be induced in the cells. One may find transport routes that are normally nonexistent. This is the case when a temperature-sensitive mutant of e-COP is expressed, leading to disruption of the Golgi apparatus. Ricin is then still able to intoxicate the cells, presumably due to induction of an endosome to ER transport that does not operate under normal conditions. 60, 61 Importantly, it has been demonstrated that toxins and other receptor-bound ligands taken up by different endocytic mechanisms can enter the same endosome and from there be sorted to the Golgi apparatus. 35, 62 Why is it necessary for a toxin to move all the way from the cell surface to the ER for translocation to the cytosol to occur? There are several points to consider: some of the toxins are activated by cellular proteases that they encounter on the way. For instance, Shiga toxin can be cleaved and activated by the enzyme furin, 1 and in cells without this enzyme, alternative processing occurring later along the pathway can activate the toxin thereby making it toxic to more cell types than would otherwise have been the case. Also, the ER membrane is, due to its low cholesterol content, probably more permeable than the plasma membrane or the endosomal membrane, a feature that might be important for transfer of molecules with carbohydrate attached to the protein backbone. One could speculate that even transport of nucleotides into the cytosol might benefit from this property. Interesting in this context is the finding that cholesterol inhibits an early step in protein translocation from the cytosol to the ER. 63 Most importantly there are, in the ER, chaperones and translocators responsible for ER to cytosol transport. [64] [65] [66] [67] There is evidence that protein disulfide isomerase (PDI) is involved in release of the enzymatically active part of cholera toxin, 64 Pseudomonas exotoxin A 68 and ricin, 69, 70 and interaction of Sec 61 with several of the protein toxins have been published. 5, 64, 71 Recently, also other translocators, derlin 1 and 2, have been described, 72, 73 and it remains to be studied to which extent these molecules can mediate transfer of toxins or conjugates made from toxins to the cytosol. At least these molecules seem to be involved in translocation of proteins from the ER to the cytosol, a feature that makes them interesting as candidates for transport of toxin/conjugates into cells.
Transcytosis in polarized epithelial cells
Both receptor-bound ligands and compounds in solution can be transported across epithelial cell layers by transcytosis, that is, the process by which vesicles pinch off from either the apical or basolateral pole of the polarized cells and mediate transfer to the opposite side, presumably via the endocytic compartment. Also for studies of transcytosis, protein toxins have proven useful, and again, a number of results have been obtained with the plant toxin ricin that can serve as a membrane marker and which can be expected to provide information also about uptake and transcytosis of compounds in solution. It is important to note that trancytosis of membrane is not necessarily subjected to the same type of regulation as certain receptors. For instance, transcytosis of pIgA receptors from the basolateral to the apical side is inhibited by the drug brefeldin A which inhibits GTP loading of ARF1, and which might thereby inhibit recruitment of coats to membranes. 74 However, when transcytosis of ricin is studied in the same cell, there is no reduction. 75 Therefore, it is important to study membrane and fluid-phase transcytosis and not only transepithelial transport of certain ligands.
Uptake of ligands and fluid can occur both from clathrin-coated pits and by clathrin-independent endocytosis in polarized epithelial cells (for instance MDCK Lessons learned from plant and bacterial toxins K Sandvig and B van Deurs cells). Importantly, and for reasons not yet understood, caveolae are present only at the basolateral side of these cells. 76 Even when Caco-2 cells, which originally do not contain caveolin 1 and caveolae, are transfected with caveolin, caveolae are formed only at the basolateral side. Thus, the uptake by clathrin-independent endocytosis at the apical side occurs by a process that is also independent of caveolae. Interestingly, this process turns out to be highly regulated, and also transcytosis is as a consequence changed. As indicated in Figure 3 , endocytosis at the apical side is upregulated by activation of heterotrimeric G proteins 77 and activation of protein kinase C, 78 by protein kinase A, 77 and by addition of brefeldin A. 75 Also, it is regulated by the cyclooxygenase pathway 79 and by calmodulin. 80 Upon addition of Nethylmaleimide (NEM) to polarized MDCK cells, ruffling and formation of macropinosomes are induced, and this process seems to be dependent on phospholipase D. 81 Interestingly, overexpression of the Rab5-effector Rabankyrin-5 was recently shown to stimulate apical and not basolateral endocytosis. 82 It is, however, possible that different types of apical clathrin-independent processes might be responsible for the responses observed. Thus, the growth conditions of a cell layer can clearly influence uptake and transcytosis of a ligand taken up by clathrinindependent endocytosis and the transfer of solutes across epithelial cells. Whether this can be exploited to influence transport in a physiological situation is not clear. We still need to clarify which proteins are involved in the actual endocytic mechanism found in such cells. So far, clathrin-independent apical endocytosis of ricin and the fluid-phase marker horseradish peroxidase (HRP) is the only endocytic process that seems to occur without GTP-hydrolysis. 83 Interestingly, by using permeabilized, polarized MDCK cells, it was found that this process is dependent on the small GTP-binding protein RhoA.
Clearly, different ligands are transcytosed and might be used to bring nucleotides across cell layers. However, the efficiencies might differ in ways we still cannot predict. For instance, transcytosis of Shiga-like toxin I and II, which both bind to the neutral glycosphingolipid Gb3, are subjected to different regulation. 84 Thus, future studies of transcytosis both of protein toxins and fluid are required to obtain a better understanding of this process and the extent to which transcellular transport of vectors can be improved.
Protein toxins used as vectors for import of DNA
Not only can the toxins here described be used to bring other proteins 10, 11 or epitopes for presentation by MHC class I 9 into cells, but protein toxins or toxin domains can also be used to facilitate entry of DNA and obtain transcription/translocation of the gene that enters. For this purpose, both toxins that enter from endosomes and those that are normally targeted to the ER can be used, and in some instances only toxin domains are included in the conjugates. Details concerning construction of toxin-nucleotide vectors have recently been described by Uherek and Wels. 85 Thus, diphtheria toxin 12,13 and anthrax toxin, 16 which normally enters from endosomes, as well as Pseudomonas exotoxin A, 14, 19 Shiga toxin, 15 and cholera toxin, [16] [17] [18] which all normally enter from the ER, have been found to mediate gene transfer. Interestingly, some of the characteristics of toxin entry have been conserved. Entry mediated by both diphtheria toxin and Pseudomonas exotoxin A can at least in some instances be inhibited by agents that counteract acidification of internal organelles. It is however not obvious that intracellular routing of a modified toxin leads to release of attached material from the organelle that is normally used by the toxin for entry into the cytosol. The possibility exists that the material might enter the cytosol to some extent from another organelle, for instance from endosomes. However, as long as only a few molecules are required in the cytosol or the nucleus to obtain a biological effect, such a transport or leakage into the cytosol could contribute to get the desired effect.
Conclusions
Protein toxins have proven useful to study intracellular pathways in general, and such knowledge is essential for drug design. Investigation of the toxins and their interactions with cells are required not only to develop strategies to prevent their toxic effect and to cure disease caused by infectious bacteria that secrete toxins, but the protein toxins can also be exploited to cure other diseases by using them as vectors to bring both proteins and nucleotides into cells.
